The prognostic value of metabolic dysfunction‐associated steatotic liver disease in acute myocardial infarction: A propensity score‐matched analysis

G Kong, G Cao, J Koh, SP Chan… - Diabetes, Obesity …, 2024 - Wiley Online Library
Aim Patients with metabolic dysfunction‐associated steatotic liver disease (MASLD) are at
increased risk of incident cardiovascular disease. However, the clinical characteristics and …

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic …

F Fogacci, M Giovannini, A Di Micoli, G Fiorini… - Nutrients, 2024 - mdpi.com
The aim of this study was to assess whether dietary supplementation with a nutraceutical
blend comprising extracts of bergamot and artichoke—both standardized in their …

Associations between estimated glucose disposal rate and arterial stiffness and mortality among US adults with non-alcoholic fatty liver disease

J Song, R Ma, L Yin - Frontiers in Endocrinology, 2024 - frontiersin.org
Background The estimated glucose disposal rate (eGDR), an effective indicator of insulin
resistance, has been related to acute coronary syndrome, ischemic stroke and heart failure …

[HTML][HTML] Chronic Liver Disease after Allogeneic Hematopoietic Cell Transplantation

B Randhawa, N Blosser, A Daly, J Storek, AA Shaheen… - Cytotherapy, 2024 - Elsevier
Background There are few descriptions of the epidemiology of chronic liver disease (CLD)
after allo-HCT. Amongst those transplanted prior to 2000, viral hepatitis was the dominant …

Cardiometabolic and Metabolic Profiles of Lean/Normal, Overweight and Obese Patients with Nonalcoholic Fatty Liver Disease

S Wang, Y Zhang, X Qi, X Xu - Diabetes, Metabolic Syndrome and …, 2024 - Taylor & Francis
Purpose Disagreements about the risk of non-obese, non-alcoholic fatty liver disease for
cardiometabolic outcomes occurred widely. This study aims to characterize the …